Editorial: Emerging roles of miRNAs in cardiovascular disease

Front Cardiovasc Med. 2023 Feb 28:10:1144849. doi: 10.3389/fcvm.2023.1144849. eCollection 2023.

Donato Santovito^{1

2

3}, Yuhua Fan⁴, Leonardo Elia^{5

6}, Joanne T M Tan^{7

8}, Emiel P C van der Vorst^{1

2

9}

¹ Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximillians-Universität (LMU), Munich, Germany.
² German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.
³ Institute for Genetic and Biomedical Research, Unit of Milan, National Research Council, Milan, Italy.
⁴ Department of Basic Medical College, Harbin Medical University (Daqing), Daqing, China.
⁵ IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
⁶ Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
⁷ Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
⁸ Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.
⁹ Aachen-Maastricht Institute for CardioRenal Disease (AMICARE), Interdisciplinary Center for Clinical Research (IZKF) and Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany.

No abstract available

Keywords: acute coronary syndrome; biomarker; cardiovascular disease; macrophages; miRNA.

Publication types

EPCvdV is funded by a grant from the Interdisciplinary Center for Clinical Research within the faculty of Medicine at the RWTH Aachen University.